Home Home Home Inbox Home Search

Event

Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study [Board No. P897]

Location: Board no. P897
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Hector Ortega

MD, ScD
GlaxoSmithKline;GSK

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Wendy C. Moore

MD
Wake Forest School of Medicine;Wake Forest Univ Sch of Med;Wake Forest University School of Medicine

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Frank C. Albers

MD, PhD
GlaxoSmithKline;GSK

Martyn J. Gilson

MSc
GSK

Robert Price

MSc
GlaxoSmithKline;GSK

View Abstract

Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search